-
-
-
-
-
-
-
Pre-Open Stock Movers 06/24: (MRIN) (RCUS) (LLY) Higher; (PRTG) (RAD) (BIIB) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Movers 07/21: (NBEV) (LXRX) (OMI) Higher; (ACAD) (PIRS) (CTSO) Lower (more...)
-
-
-
-
-
-
-
Pieris Pharma (PIRS) Reports Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy
-
-
-
-
-
-
-
Pieris Pharmaceuticals Announces Pricing of its Public Offering
-
-
-
-
-
-
-
Pieris Pharma (PIRS) Reports Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343
-
-
-
-
-
-
-
Pieris Pharma (PIRS) Enters $35 ATM Offering with Cowen
-
-
-
-
-
-
-
Form S-3 PIERIS PHARMACEUTICALS,
-
70,527 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

